Hongying Wang

机构：Binzhou Medical University, Shandong University of Aeronautics · ORCID：0000-0002-3963-1155

发表论文 54 篇 · 总被引 42 次 · h-index 3

代表论文

• IGSF9-targeted therapy inhibits the progression of acute myeloid leukemia (2025 · Blood Advances · 被引 4)
• Targeting Immunoglobulin Superfamily Member 9 (IGSF9) to Overcome Acute Myeloid Leukemia Resistance to CAR-T Therapy (2026 · Research Square)
• Figure S8 from Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy (2025)
• Figure S7 from Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy (2025)
• Figure S2 from Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy (2025)
• Figure S6 from Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy (2025)